CLINICAL TRIALS PROFILE FOR ZAROXOLYN
✉ Email this page to a colleague
All Clinical Trials for ZAROXOLYN
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00649051 ↗ | Fasting Study of Metolazone Tablets 2.5 mg and Zaroloxyn® Tablets 2.5 mg | Completed | Mylan Pharmaceuticals | Phase 1 | 2002-12-01 | The objective of this study was to investigate the bioequivalence of Mylan metolazone 2.5 mg tablets to Celltech Zaroxolyn® 2.5 mg tablets following a single, oral 10 mg (4 x 2.5 mg) dose administration under fasting conditions. |
NCT00649181 ↗ | Fasting Study of Metolazone Tablets 5 mg and Zaroloxyn® Tablets 5 mg | Completed | Mylan Pharmaceuticals | Phase 1 | 2003-10-01 | The objective of this study was to investigate the bioequivalence of Mylan metolazone 5 mg tablets to Celltech Zaroxolyn® 5 mg tablets following a single, oral 10 mg (2 x 5 mg) dose administration under fasting conditions. |
NCT00650195 ↗ | Fasting Study of Metolazone Tablets 10 mg and Zaroloxyn® Tablets 10 mg | Completed | Mylan Pharmaceuticals | Phase 1 | 2004-02-01 | The objective of this study was to investigate the bioequivalence of Mylan metolazone 10 mg tablets to Celltech Zaroxolyn® 10 mg tablets following a single, oral 10 mg (1 x 10 mg) dose administration under fasting conditions. |
NCT00904488 ↗ | Oral Metolazone and Intermittent Intravenous Furosemide Versus Continuous Infusion Furosemide in Acute Heart Failure | Terminated | University of Illinois at Chicago | Phase 4 | 2008-10-01 | The purpose of this prospective, randomized, open-label study is to compare two diuretic strategies in patients with acute decompensated heart failure (ADHF): the addition of an oral thiazide diuretic to intravenous bolus (IVB) loop diuretic will be compared to transition from IVB to continuous infusion (CI) loop diuretic. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for ZAROXOLYN
Condition Name
Clinical Trial Locations for ZAROXOLYN
Trials by Country
Clinical Trial Progress for ZAROXOLYN
Clinical Trial Phase
Clinical Trial Sponsors for ZAROXOLYN
Sponsor Name